Takeda Becomes Founding Sponsor of LabCentral to Help Life Sciences Startups Accelerate New Medical Treatments
CAMBRIDGE, Mass., July 21, 2022 /PRNewswire/ -- LabCentral today announced that Takeda, a global biopharmaceutical leader headquartered in Japan with a global U.S. hub located in Massachusetts, will become a LabCentral Founding Sponsor. Takeda will provide funding over a period of three years to support LabCentral's biotech incubator located at 700 Main Street in the heart of Kendall Square in Cambridge, Mass. The Founding Sponsorship will provide strategic support for LabCentral's operations at the location, including its shared lab space and a robust range of programs designed to help its community of biotech startup residents accelerate their research and development.
- CAMBRIDGE, Mass., July 21, 2022 /PRNewswire/ -- LabCentral today announced that Takeda, a global biopharmaceutical leader headquartered in Japan with a global U.S. hub located in Massachusetts, will become a LabCentral Founding Sponsor.
- LabCentral will allow a maximum of seven Founding Sponsorships for LabCentral 700, including up to four Sponsors from the pharmaceutical/biotech industry.
- Takeda is joining existing Founding Sponsors Massachusetts Life Sciences Center (MLSC), Triumvirate Environmental, Johnson & Johnson Innovation, Roche and Eppendorf.
- A private, non-profit institution, LabCentral was founded in 2013 as a launchpad for high potential life-sciences and biotech startups.